Michael Reitermann has been appointed the new CEO of Siemens Healthcares U.S. organization.
June 29, 2009 – Siemens Healthcare officially announced today that Michael Reitermann has been appointed the new CEO of Siemens Healthcare’s U.S. organization, effective July 1, 2009.
In his new position, Reitermann will lead the marketing, sales and service functions for Siemens Healthcare in the U.S., including the medical imaging, therapy and health care information technology businesses. He will be based at the U.S. headquarters in Malvern, Pa. Reitermann succeeds Dr. Heinrich Kolem, who will assume the role of global head of Siemens Healthcare’s Angiography, Fluoroscopy and X-ray business unit, based in Forchheim, Germany.
Reitermann has enjoyed a long career with Siemens. Among other things, he worked as a senior project manager at the corporate strategies division as well as a partner in Siemens Management Consulting. Reitermann also served as vice president for sales, marketing and innovation of the Siemens Angiography, Fluoroscopy and X-ray business unit. Most recently, as CEO of Siemens Molecular Imaging (MI) Business Unit, and president of the former Nuclear Medicine division since July 2002, Reitermann was responsible for the establishment and implementation of MI’s business objectives around the world.
Heinrich Kolem will take on a new challenge, assuming the role of global head of Siemens Healthcare’s Angiography, Fluoroscopy and X-ray business unit. Since 2006, Kolem was the CEO of the Siemens Healthcare organization in the United States overseeing launches of innovative new imaging systems such as the SOMATOM Definition Flash, MAGNETOM Essenza, Biograph mCT, the Acuson S2000 and other novel innovations. Kolem started his Siemens career in the field of Magnetic Resonance Imaging in 1989.
For more information: www.siemens.com/healthcare
July 28, 2026 
